Guardant Health GH
NASDAQ GH
$182.99 +8.09 (+4.63%)
As of: Sep 17, 2026 · 3:59 PM EDT

Guardant Health (GH) Net Cash Flow Growth (3y) (2020 - 2026)

Analysis

Guardant Health (GH) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 29.31%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 89.23%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -35.93%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 11.05%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 28.25%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 82.30%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -9.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.05%
Mar 31, 2026 95.50%
Dec 31, 2025 -123.74%
Sep 30, 2025 6.84%
Jun 30, 2025 42.09%
Mar 31, 2025 28.24%
Dec 31, 2024 44.88%
Sep 30, 2024 -48.69%
Jun 30, 2024 -49.52%
Mar 31, 2024 -27.80%
Dec 31, 2023 -0.71%
Sep 30, 2023 119.11%
Jun 30, 2023 57.76%
Mar 31, 2023 108.89%
Dec 31, 2022 -65.79%
Sep 30, 2022 -26.88%
Jun 30, 2022 -167.95%
Mar 31, 2022 83.43%
Dec 31, 2021 -146.64%
Sep 30, 2021 -227.14%